Beijing, China

Di Kang

This inventor holds 3 USPTO granted patents and 5 published patent applications and 2 EPO patents. Top assignee: Jacobio Pharmaceuticals Co., Ltd.. Active years: 2020-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Di Kang. Retrieved from https://idiyas.com/inventor/di-kang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.8

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Discovering the Innovations of Inventor Di Kang

Introduction

Di Kang is an innovative inventor based in Beijing, China, known for his significant contributions to medicinal chemistry and pharmacology. With a total of three patents to his name, Kang is making strides in the development of therapeutic compounds targeting SHP2-mediated disorders.

Latest Patents

Among his latest inventions are several patents focusing on heterocyclic derivatives useful as SHP2 inhibitors. The first patent outlines a compound of formula I, detailing its synthesis and application for treating SHP2 mediated disorders. This invention also provides a pharmaceutical composition that incorporates the said compound. Another patent from Kang relates to novel pyrazine derivatives, illustrating their potential as SHP2 inhibitors as well. This work encompasses methods for producing these compounds and employing them for the treatment of SHP2-mediated disorders, showcasing the depth of his research and commitment to advancing medical treatments.

Career Highlights

Di Kang works at Jacobio Pharmaceuticals Co., Ltd., a company recognized for its focus on innovative drug discovery and development. His team has made impressive advancements in the field, particularly in the search for effective treatments for serious medical conditions, further solidifying his reputation as an accomplished inventor.

Collaborations

Kang collaborates closely with colleagues such as Cunbo Ma and Panliang Gao, pooling their expertise to drive successful outcomes in their research projects. This collaborative approach has helped enhance the creativity and effectiveness of their inventions.

Conclusion

Through his inventive spirit and dedication to scientific research, Di Kang continues to influence the pharmaceutical landscape, particularly in the treatment of SHP2 mediated disorders. His contributions stand testament to the importance of innovation in medicine and the role of inventors like Kang in shaping a healthier future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…